Venus Remedies Limited (BOM:526953)
India · Delayed Price · Currency is INR 1,780.10
-6.70 (-0.37%)
At close: Aug 17, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 23.88 billion as of August 17, 2026. Its market cap has increased by 278.52% in one year.
Market Cap
23.88B
Enterprise Value
22.97B
Revenue
8.11B
Ranking
n/a
PE Ratio
20.56
Stock Price
1,780.10
ChartMarket Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 23.88B, an increase of 9,735.63%. That is a compound annual growth rate of 23.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 23.88B | 132.96% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 42.24B |
| Novartis India | 39.18B |
| Unichem Laboratories | 37.93B |
| Kwality Pharmaceuticals | 35.74B |
| Hikal | 26.87B |
| Fredun Pharmaceuticals | 25.60B |
| Shukra Pharmaceuticals | 18.21B |
| TTK Healthcare | 16.40B |